Early normalisation of aminotransferase predicts complete biochemical remission in autoimmune hepatitis patients

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 1, 2011, Pages 107-109

  Wang, Q ^a   Qiu, D ^a   Ma, X ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; AZATHIOPRINE; PREDNISOLONE;

AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; COMORBIDITY; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LETTER; PREDICTIVE VALUE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE;

HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TRANSAMINASES; TREATMENT OUTCOME;

EID: 79958094881     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04690.x     Document Type: Letter

References (4)

1. Yeoman AD, Longhi MS, Heneghan MA,. Review article: the modern management of autoimmune hepatitis. Aliment Pharmacol Ther 2010; 31: 771-87.
2. Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-213.
3. Czaja AJ,. Rapidity of treatment response and outcome in type 1 autoimmune hepatitis. J Hepatol 2009; 51: 161-7.
4. Qiu D, Wang Q, Wang H, et al. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol 2011; 54: 340-7.